~~<i id='CA24EDDCCC'><strike id='CA24EDDCCC'><tt id='CA24EDDCCC'><pre id='CA24EDDCCC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

leisure time

author：focus 2025-09-30 09:31:10 - browse：7163

A man, who is suffering from frostbite, displays his hands. -- health coverage from STAT — Jon Cherry/Getty Images

Two days after his right hand froze, Hart Bezner realized for the first time that he might lose it.

The retired physics professor was sitting in an emergency room in Whitehorse, the capital of Canada’s Yukon territory, where two doctors and a pharmacist were taking an unusual amount of interest in the appendage and the pink blisters that now covered it.

“Will I lose my hand?” he remembers asking. “Will this go away?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Medicare coverage of Wegovy, once blocked, now looks possible

explore

knowledge

focus

Wikipedia

focus

AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu

WSS

Medicare coverage of Wegovy, once blocked, now looks possible

Thermo Fisher plant for manufacturing gene therapies to expand

RaDonda Vaught links Vanderbilt hospital issues to patient death

Microbiome research is starting to find links to chronic diseases

HHS secretary Becerra pressed on Change HealthCare cyberattack

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

knowledge

leisure time

explore

Peter Hotez and the public health issue of online harassment

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

After affirmative action ruling, medical educators look to 'holistic review'

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

Duchenne breakthrough therapy leaves behind pioneering families

Senate HELP committee spars over health care workforce policies

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Anesthesiologist group: stop taking Ozempic before surgery

WuXi out of biotech trade group, U.S. and China relations to blame

explore

First U.S. drug developed to treat liver disease MASH is approved

Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

STAT Virtual Event: Putting AI to the Test

Why depression after traumatic brain injury is distinct

As AI in medicine takes off, can 'human in the loop' prevent harm?

knowledge

focus

Wikipedia

focus